Solu Therapeutics
- Employees
- 1–10
- Business Model
- B2B
- Website
- solutherapeutics.com
- Total Funding
- $72.0M
- Last Round
- $41.0M Series AApr 2025
- Rounds
- 2
About
Biotech company developing groundbreaking medicines to transform disease treatment.
Summary
Solu Therapeutics is a Biotech company. It has raised $72.0M in total across 2 rounds, most recently a $41.0M Series A round in Apr 2025. Investors include Hengdian Group Capital, Eli Lilly and DCVC (Data Collab).
Tech & App Stack
5 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Apr 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/solu-therapeutics"><img src="https://indexed.vc/api/badge/company/solu-therapeutics" alt="Solu Therapeutics on Indexed.vc" width="260" height="76" /></a>